Vaspin
Vaspin (Visceral Adipose Tissue-Derived Serine Protease Inhibitor)
An adipokine with insulin-sensitizing and anti-inflammatory properties. Produced by visceral adipose tissue and has protective effects against obesity-related metabolic dysfunction.
Mechanism of Action
Vaspin inhibits serine proteases that degrade insulin-sensitizing adipokines. It activates insulin receptor signaling, reduces inflammation, and has protective effects on pancreatic beta cells.
Health Claims & Evidence
Improves insulin sensitivity
Anti-inflammatory effects
Protects pancreatic beta cells
Short-Term Effects
Improved insulin sensitivity, anti-inflammatory effects.
Long-Term Effects
Research use primarily.
Side Effects
Limited human data.
Contraindications
Limited human safety data.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
Vaspin and insulin sensitivity
Hida et al. · Nature Medicine · 2005
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on Vaspin and related peptides, and prepare an educational research summary.
Explore Research